Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

481 ARTÍCULOS , VIENDO DEL 451 AL 465

Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis

Liebermann-Jordanidis H, Roheger M, Boosfeld L, Franklin J, Kalbe E.

J Parkinsons Dis. 2022;12(6):1749-1782. doi: 10.3233/JPD-223238.

The role of basket trials in drug development for neurodegenerative disorders

Cummings J, Montes A, Kamboj S, Cacho JF.

Alzheimers Res Ther. 2022 May 25;14(1):73. doi: 10.1186/s13195-022-01015-6.

The promise of amplification assays for accurate early detection of α-synucleinopathies: A review

Kurapova R, Chouliaras L, O'Brien JT.

Exp Gerontol. 2022 Aug;165:111842. doi: 10.1016/j.exger.2022.111842. Epub 2022 May 24.

Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier

Zhang J, Yang T, Huang W, Yu Y, Sun T.

Curr Med Chem. 2022;29(39):6063-6083. doi: 10.2174/0929867329666220527121943.

Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases

Fan Y, Chen Z, Zhang M.

J Transl Med. 2022 Jun 27;20(1):291. doi: 10.1186/s12967-022-03493-6.

Striatal Blood-Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study

Pineda-Pardo JA, Gasca-Salas C, Fernández-Rodríguez B, Rodríguez-Rojas R, Del Álamo M, Obeso I, Hernández-Fernández F, Trompeta C, Martínez-Fernández R, Matarazzo M, Mata-Marín D, Guida P, Duque A, Albillo D, Plaza de Las Heras I, Montero JI, Foffani G, Toltsis G, Rachmilevitch I, Blesa J, Obeso JA.

Mov Disord. 2022 Oct;37(10):2057-2065. doi: 10.1002/mds.29134. Epub 2022 Jun 28.

Promoting independence in Lewy body dementia through exercise: the PRIDE study

Inskip MJ, Mavros Y, Sachdev PS, Hausdorff JM, Hillel I, Singh MAF.

BMC Geriatr. 2022 Aug 9;22(1):650. doi: 10.1186/s12877-022-03347-2.

Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review)

Król-Grzymała A, Sienkiewicz-Szłapka E, Fiedorowicz E, Rozmus D, Cieślińska A, Grzybowski A.

Int J Mol Sci. 2022 Sep 4;23(17):10123. doi: 10.3390/ijms231710123.

Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids

Vaz M, Soares Martins T, Henriques AG.

J Neurochem. 2022 Nov;163(4):266-309. doi: 10.1111/jnc.15697. Epub 2022 Oct 22.

Case Study 3: A 58-Year-Old Woman Referred for Evaluation of Suspected Alzheimer Dementia

Maneval J, Woods JK, Feany MB, Miller MB, Silbersweig DA, Gale SA, Daffner KR, McGinnis SM.

J Neuropsychiatry Clin Neurosci. 2022 Fall;34(4):307-315. doi: 10.1176/appi.neuropsych.20220113.

Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases

Zhang J, Chen Z, Chen H, Deng Y, Li S, Jin L.

Biosensors (Basel). 2022 Nov 24;12(12):1074. doi: 10.3390/bios12121074.

[The role of hyperuricemia in the development of cognitive changes in the elderly.]

Kunitskaya NA, Ariev AL.

Adv Gerontol. 2022;35(5):775-782.

Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review

Alqarni S, Alsebai M.

Front Endocrinol (Lausanne). 2022 Dec 22;13:1032192. doi: 10.3389/fendo.2022.1032192. eCollection 2022.

Epilepsy in Early Onset Alzheimer's Disease

Haoudy S, Jonveaux T, Puisieux S, Epstein J, Hopes L, Maillard L, Aron O, Tyvaert L.

J Alzheimers Dis. 2022;85(2):615-626. doi: 10.3233/JAD-210681.

Towards Defining the Neuroanatomical Basis of Late-Onset Psychiatric Symptoms

Barker MS, Cosentino SA, Fremont R, Devanand DP, Huey ED.

J Geriatr Psychiatry Neurol. 2022 Nov;35(6):751-762. doi: 10.1177/08919887221090213. Epub 2022 Apr 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias